Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rogers, Lauren
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B	Completed	3	640	US, RoW	HEPLISAV-B, ENGERIX-B	National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation	HIV Infection, Hepatitis B	08/24	08/24
PURGE-C, NCT04042740: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection	Completed	2	45	US, RoW	Glecaprevir/Pibrentasvir (G/P), Mavyret	Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, AbbVie, National Institute of Allergy and Infectious Diseases (NIAID)	Hepatitis C Infection, HIV Infection	05/23	08/23
ALPESTRIA-1, NCT06425055: Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1	Active, not recruiting	2	20	Europe, US	Vonafexor, EYP001a	Enyo Pharma	Alport Syndrome	07/25	10/25
ExPAND, NCT06243068: Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial	Recruiting	N/A	3000	US	Educate and Engage, Educate and Engage Plus Kidney Supportive Care Program	George Washington University, West Virginia University Research Corporation, University of Bristol, Patient-Centered Outcomes Research Institute	Chronic Kidney Disease	12/27	06/28